Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SIMI BHARDWAJ SETHI

Eye and Vision Services Providers Optometrist

NPI
1144382946
CMS profile
994036
Location
MANAHAWKIN, NJ

General Payments · PY2018–2024

$2,715.26

  • Reported across 52 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$241.01

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $241.01 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Astellas Pharma US Inc $80.52 4
Alcon Laboratories Inc $68.31 4
Bausch & Lomb Americas Inc. $30.97 2
ABBVIE INC. $27.96 2
Tarsus Pharmaceuticals, Inc. $17.18 1
Amgen Inc. $16.07 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,131.59 11
PY2019 $913.89 7
PY2020 $108.75 7
PY2021 $123.81 4
PY2022 $127.66 5
PY2023 $68.55 4
PY2024 $241.01 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.84 02/20/2024 Food and Beverage Undisputed 01/23/2026 1106058938 CMS
ABBVIE INC. $13.12 04/17/2024 Food and Beverage Undisputed 01/23/2026 1106058940 CMS
Alcon Vision LLC $15.95 02/22/2024 Food and Beverage Undisputed 01/23/2026 1110645833 CMS
Alcon Vision LLC $17.23 03/12/2024 Food and Beverage Undisputed 01/23/2026 1110645835 CMS
Alcon Vision LLC $19.29 09/11/2024 Food and Beverage Undisputed 01/23/2026 1110645837 CMS
Alcon Vision LLC $15.84 10/02/2024 Food and Beverage Undisputed 01/23/2026 1110645831 CMS
Amgen Inc. $16.07 04/22/2024 Food and Beverage Undisputed 01/23/2026 1116104245 CMS
Astellas Pharma US Inc $19.08 02/02/2024 Food and Beverage Undisputed 01/23/2026 1139451706 CMS
Astellas Pharma US Inc $22.20 03/07/2024 Food and Beverage Undisputed 01/23/2026 1139451660 CMS
Astellas Pharma US Inc $19.68 05/16/2024 Food and Beverage Undisputed 01/23/2026 1139451958 CMS
Astellas Pharma US Inc $19.56 08/16/2024 Food and Beverage Undisputed 01/23/2026 1139425623 CMS
Bausch & Lomb Americas Inc. $13.38 01/31/2024 Food and Beverage Undisputed 01/23/2026 1140450046 CMS
Bausch & Lomb Americas Inc. $17.59 12/15/2024 Food and Beverage Undisputed 01/23/2026 1140450044 CMS
Tarsus Pharmaceuticals, Inc. $17.18 07/24/2024 Food and Beverage Undisputed 01/23/2026 1139131358 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.